Inhibition of Akt/mTOR pathway overcomes intrinsic resistance to dasatinib in triple-negative breast cancer.
Biochem Biophys Res Commun
; 533(4): 672-678, 2020 12 17.
Article
in En
| MEDLINE
| ID: mdl-33036754
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Protein Kinase Inhibitors
/
Proto-Oncogene Proteins c-akt
/
TOR Serine-Threonine Kinases
/
Triple Negative Breast Neoplasms
/
Dasatinib
/
Antineoplastic Agents
Limits:
Female
/
Humans
Language:
En
Journal:
Biochem Biophys Res Commun
Year:
2020
Type:
Article
Affiliation country:
Japan